RT-qPCR results exhibited that only FBXL19 among the three targets was evidently up-regulated in glioma cells compared to normal controls (Fig. 4a), which further confirmed by western blot (Additional file 2: Fig. S2A). The gene discussed is FBXL19; the disease is central nervous system cancer.